Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-08

Clinical Trial Update: Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial exploring vitamin D effects on ADAMTS13 and interleukin-6 pathways in acute myeloid leukemia with vitamin D deficiency; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Zagazig University | Conditions: Acute Myeloid Leukemia, Vitamin D Deficiency | Phase 1, Phase 2 | Status: COMPLETED